Viant price target raised to $10 from $8 at Canaccord

Canaccord analyst Maria Ripps raised the firm’s price target on Viant to $10 from $8 and keeps a Buy rating on the shares. The firm said they reported solid Q4 results, as the company is seeing increasing traction with upper mid-market customers, and while 2H24 comps are meaningfully more difficult and could drive some second-half growth deceleration, Canaccord thinks these results could help support increasing investor interest over time.